We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

158 hedge funds and large institutions have $344M invested in Maravai LifeSciences in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $1.08M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

1% less funds holding

Funds holding: 159 → 158 (-1)

2% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 52

6.28% less ownership

Funds ownership: 89.23% → 82.95% (-6.3%)

18% less capital invested

Capital invested by funds: $421M → $344M (-$77.2M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
158
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
1.94%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
28
Increased
51
Reduced
52
Closed
24
Calls
$1.29M
Puts
$1.08M
Net Calls
+$207K
Net Calls Change
-$3.15M

Top Buyers

1
B
Braidwell
Connecticut
+$6.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.94M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.49M
4
First Eagle Investment Management
First Eagle Investment Management
New York
+$2.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.89M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$18.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.67M
3
MFS
Mirabella Financial Services
United Kingdom
-$6.86M
4
1WCM
12 West Capital Management
New York
-$5.63M
5
EP
Eversept Partners
New York
-$2.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$543K -$1.85M -547,129 -74%
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$528K +$633K +186,639 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$517K -$39K -11,500 -7%
XT
54
XTX Topco
Cayman Islands
$491K +$328K +96,730 +126%
GCP
55
GSA Capital Partners
United Kingdom
$477K +$571K +168,551 New
SO
56
STRS Ohio
Ohio
$465K – – –
VC
57
VarCov Co
Connecticut
$458K +$548K +161,685 New
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$404K -$26.9K -7,928 -5%
T. Rowe Price Associates
59
T. Rowe Price Associates
Maryland
$399K +$84K +24,773 +21%
Russell Investments Group
60
Russell Investments Group
United Kingdom
$393K +$20.3K +6,002 +5%
Mirae Asset Global ETFs Holdings
61
Mirae Asset Global ETFs Holdings
Hong Kong
$346K +$16.7K +4,932 +4%
ECP
62
Epacria Capital Partners
Colorado
$283K – – –
EF
63
Empowered Funds
Pennsylvania
$255K -$17.5K -5,173 -5%
Ameriprise
64
Ameriprise
Minnesota
$242K +$244K +71,912 +528%
EC
65
EntryPoint Capital
New York
$241K +$289K +85,203 New
Ohio Public Employees Retirement System (OPERS)
66
Ohio Public Employees Retirement System (OPERS)
Ohio
$238K +$285K +84,178 New
AQR Capital Management
67
AQR Capital Management
Connecticut
$234K -$96.9K -28,595 -26%
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$224K -$113K -33,332 -30%
HF
69
HRT Financial
New York
$215K -$989K -291,628 -79%
STA
70
Summit Trail Advisors
New York
$209K -$22.1K -6,518 -8%
AWF
71
Alpha Wealth Funds
Utah
$207K – – –
Mitsubishi UFJ Asset Management
72
Mitsubishi UFJ Asset Management
Japan
$184K -$5.43K -1,603 -2%
Bank of Montreal
73
Bank of Montreal
Ontario, Canada
$168K – – –
BFM
74
Boothbay Fund Management
New York
$156K +$187K +55,060 New
MIM
75
MetLife Investment Management
New Jersey
$152K +$34.7K +10,239 +24%
1 2
3
4 5

MRVI Hedge Fund Activity: Q1 2026 in Review

158 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q1 2026, worth a combined $344M — down 18% from $421M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new MRVI positions and 24 closed out — a net gain of 4 holders — while 51 added to existing stakes and 52 trimmed.

The largest buyer was Braidwell, adding an estimated $6.4M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $18.1M.

  • 158 institutional investors held Maravai LifeSciences (MRVI) as of Q1 2026, down from 159 in Q4 2025.
  • Funds reported $344M of Maravai LifeSciences stock for Q1 2026, down 18% quarter-over-quarter.
  • 28 funds opened new Maravai LifeSciences positions in Q1 2026 and 24 closed out, a net change of +4 holders.
  • The largest Maravai LifeSciences buyer in Q1 2026 was Braidwell, an estimated $6.4M added.
  • The largest Maravai LifeSciences seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $18.1M sold.

Based on aggregated 13F filings for Q1 2026.